Name	Value
Compound	MLS-2384
Investigated event	Influence on cell viability
Experiment type	MTT
Concentration	2.50 µM
Cell line	MDA-MB-468
Organism	Homo sapiens
Animal model
STAT protein
Other

MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells. Cancer biology & therapy Lucy Liu, Nicolas Gaboriaud, Konstantina Vougogianopoulou, Yan Tian, Jun Wu, Wei Wen, Leandros Skaltsounis, Richard Jove, 15, 2, None, 2013-11-01, 10.4161/cbt.26721 DOI: 10.4161/cbt.26721 PUBMED: 24100507 PMCID: PMC3928133